Jul 20, 2024, 21:28
Erman Akkus: Hormone replacement therapy and colorectal cancer
Erman Akkus, Medical Oncologist at Ankara University, shared on X:
“Hormone replacement therapy (estrogen plus progestin) and colorectal cancer WHI trial 24-year results
-No influence on CRC incidence
-No difference in CRC deaths
No clinically meaningful benefit (in contrast to fewer CRC reported in the first 5-year results).”
Estrogen Plus Progestin and Colorectal Cancer: Long-Term Findings From the Women’s Health Initiative Randomized Clinical Trial published in JCO
Authors: Rowan T. Chlebowski, Aaron K. Aragaki, Kathy Pan, Juhua Luo, Thomas E. Rohan, Karen C. Johnson, Jean Wactawski-Wende, Su Yon Jung, Qian Xiao, JoAnn E. Manson, and Michael S. Simon.
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 09:55
Nov 21, 2024, 09:28
Nov 21, 2024, 09:23
Nov 21, 2024, 09:04
Nov 21, 2024, 06:49